These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3768795)

  • 1. Effects of subchronic pyridostigmine pretreatment on the toxicity of soman.
    Shiloff JD; Clement JG
    Can J Physiol Pharmacol; 1986 Jul; 64(7):1047-9. PubMed ID: 3768795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel tertiary pyridostigmine derivative [3-(N,N-dimethylcarbamyloxy)-1-methyl-delta 3-tetrahydropyridine]: anticholinesterase properties and efficacy against soman.
    Ray R; Clark OE; Ford KW; Knight KR; Harris LW; Broomfield CA
    Fundam Appl Toxicol; 1991 Feb; 16(2):267-74. PubMed ID: 2055358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of oral pyridostigmine pretreatment and cholinolytic-oxime therapy against soman intoxication in nonhuman primates.
    von Bredow JD; Adams NL; Groff WA; Vick JA
    Fundam Appl Toxicol; 1991 Nov; 17(4):761-70. PubMed ID: 1778362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of antidote protection against soman by pyridostigmine, HI-6 and acetylcholinesterase.
    Maxwell DM; Brecht KM; Doctor BP; Wolfe AD
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1085-9. PubMed ID: 8450452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of pyridostigmine pretreatment on oxime efficacy against intoxication by soman or VX in rats.
    Anderson DR; Harris LW; Woodard CL; Lennox WJ
    Drug Chem Toxicol; 1992; 15(4):285-94. PubMed ID: 1459041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity.
    Maxwell DM; Brecht KM; Lenz DE; O'Neill BL
    J Pharmacol Exp Ther; 1988 Sep; 246(3):986-91. PubMed ID: 3418520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of subacute pyridostigmine administration on mammalian skeletal muscle function.
    Adler M; Deshpande SS; Foster RE; Maxwell DM; Albuquerque EX
    J Appl Toxicol; 1992 Feb; 12(1):25-33. PubMed ID: 1564249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbamoylated enzyme reversal as a means of predicting pyridostigmine protection against soman.
    Ellin RI; Kaminskis A
    J Pharm Pharmacol; 1989 Sep; 41(9):633-6. PubMed ID: 2573709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evaluation of prophylactic efficacy of newly developed reversible inhibitors of acetylcholinesterase in soman-poisoned mice - a comparison with commonly used pyridostigmine.
    Kassa J; Korabecny J; Sepsova V; Tumova M
    Basic Clin Pharmacol Toxicol; 2014 Dec; 115(6):571-6. PubMed ID: 24842281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral toxicity of anticholinesterases in primates: chronic pyridostigmine and soman interactions.
    Blick DW; Kerenyi SZ; Miller S; Murphy MR; Brown GC; Hartgraves SL
    Pharmacol Biochem Behav; 1991 Mar; 38(3):527-32. PubMed ID: 2068189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reversal by pyridostigmine of neuromuscular block produced by soman.
    French MC; Wetherell JR; White PD
    J Pharm Pharmacol; 1979 May; 31(5):290-4. PubMed ID: 37297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticonvulsants for poisoning by the organophosphorus compound soman: pharmacological mechanisms.
    Shih TM; Koviak TA; Capacio BR
    Neurosci Biobehav Rev; 1991; 15(3):349-62. PubMed ID: 1683477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low concentrations of pyridostigmine prevent soman-induced inhibition of GABAergic transmission in the central nervous system: involvement of muscarinic receptors.
    Santos MD; Pereira EF; Aracava Y; Castro NG; Fawcett WP; Randall WR; Albuquerque EX
    J Pharmacol Exp Ther; 2003 Jan; 304(1):254-65. PubMed ID: 12490599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of pyridostigmine in reversing neuromuscular blockade produced by soman.
    Dirnhuber P; Green DM
    J Pharm Pharmacol; 1978 Jul; 30(7):419-25. PubMed ID: 27607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Evaluation of Benefit of Newly Prepared Reversible Inhibitors of Acetylcholinesterase and Commonly Used Pyridostigmine as Pharmacological Pretreatment of Soman-Poisoned Mice.
    Kassa J; Korábečný J; Nepovimová E
    Acta Medica (Hradec Kralove); 2017; 60(1):37-43. PubMed ID: 28418831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure.
    Haigh JR; Adler M; Apland JP; Deshpande SS; Barham CB; Desmond P; Koplovitz I; Lenz DE; Gordon RK
    Chem Biol Interact; 2010 Sep; 187(1-3):416-20. PubMed ID: 20144889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subchronic administration of various pretreatments of nerve agent poisoning. II. Compared efficacy against soman toxicity.
    Lallement G; Foquin A; Dorandeu F; Baubichon D; Carpentier P
    Drug Chem Toxicol; 2001 May; 24(2):165-80. PubMed ID: 11360433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the neuroprotective efficacy of pharmacological pretreatment and antidotal treatment in soman-poisoned rats.
    Kassa J; Krejcová G; Samnaliev I
    Acta Medica (Hradec Kralove); 2003; 46(3):101-7. PubMed ID: 14677718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time Course, Behavioral Safety, and Protective Efficacy of Centrally Active Reversible Acetylcholinesterase Inhibitors in Cynomolgus Macaques.
    Hamilton LR; Schachter SC; Myers TM
    Neurochem Res; 2017 Jul; 42(7):1962-1971. PubMed ID: 27900576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity of anticholinesterases: interactions of pyridostigmine and physostigmine with soman.
    Harris LW; Lennox WJ; Talbot BG; Anderson DR; Swanson DR
    Drug Chem Toxicol; 1984; 7(5):507-26. PubMed ID: 6510256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.